Twin Health uses AI digital twins to improve health

Digital health startup Twin Health is evaluating an experimental AI service that builds a virtual representation of a patient's metabolism to predict reactions to food and treatments. The program, currently available only through select corporate or private health insurance plans, requires participants to supply intensive biological data over a 90-day period. Setup hardware includes Dexcom G7 continuous glucose monitors, an Apple Watch, a smart scale, a blood pressure cuff, targeted supplements, and comprehensive blood panels from Quest Diagnostics.

The platform uses this continuous stream of biometric information alongside machine learning algorithms to model blood sugar fluctuations. Within the Twin Health app, meals are color-coded in red, orange, or green based on predicted glucose spikes, giving users real-time guidance on dietary choices and physical activity. The digital twin continuously updates its predictive accuracy as users log their daily meal data, weight measurements, and exercise routines while receiving guidance from human coaches and physicians.

In real-world tracking, the platform demonstrated concrete physiological impacts over a 100-day trial period. User metrics showed a nine-point increase in overall metabolic health scores, alongside a drop in triglycerides of 70mg/dL and marked reductions in hs-CRP, a primary biomarker for systemic inflammation. Additionally, the system helped reverse elevated liver enzymes and improved insulin resistance without drastic weight loss, proving the potential utility of virtual metabolic modeling for managing chronic conditions.

For healthcare practitioners and developers, these results highlight both the promise and operational hurdles of personalized digital twin technology. While the high-volume data collection creates significant tracking fatigue and requires deep patient trust regarding sensitive health data, the model demonstrates how preventive metabolic coaching can yield measurable clinical progress before expanding into higher-stakes applications like oncology or personalized drug dosing.